Mizuho Raises UnitedHealth (UNH) Price Target to $500

Mizuho reiterated its Outperform rating on UnitedHealth Group Incorporated (NYSE: UNH) on October 22, 2026, while lifting its price target to $500.0 from $493.0. The firm shared its updated view in a research note on the same day the stock closed at $425.52. Mizuho joins several other major financial institutions tracking the health care provider.

UNH UnitedHealth Group Incorporated

$419.26 ▲ +27.09% year to date

1M 3M YTD

Daily close · Oct 20, 2026

Mizuho's Call on UnitedHealth Group

Mizuho's decision to maintain its Outperform rating signals confidence in the company's path forward, backed by an upward revision to its price target. Prior to this update, the firm held a $493.0 target on the shares. Other firms have also adjusted their views recently. On October 15, 2026, TD Cowen reiterated a Hold rating with a $402.0 target. The next day, Bernstein maintained its Outperform rating while adjusting its target from $512.0 to $500.0, and JP Morgan kept an Overweight rating, moving its target from $516.0 to $524.0. RBC Capital maintained an Outperform rating on October 20, 2026, lifting its target from $478.12 to $498.0. Across Wall Street, 25 analysts give the stock a consensus buy rating, with a mean price target of $478.12.

Other Institutional Activity in UnitedHealth Group

Other large funds have also adjusted their holdings in the health care provider. Pictet North America Advisors grew its holdings by 1,710.0 shares, ending with 5,129.0 shares worth about $1,882,753.0 following a 50.0% increase. Meanwhile, Global Strategic Investment Solutions closed out its position by selling 522.0 shares, leaving it with zero shares.

UnitedHealth Group Incorporated Stock Up 1.3%

UnitedHealth Group recently traded around $424.61 as of October 22, 2026, down about 0.2% from its event-day close. The shares sit below Mizuho's $500.0 target and remain about 8.0% under their 52-week high of $461.62. At the same time, the stock trades well above its 50-day moving average of $387.80 and its 200-day moving average of $360.27.

Recent Earnings

UnitedHealth Group generated $450,059,010,048.0 in trailing-twelve-month revenue with an EPS of $15.55. The company posts a net profit margin of 3.5% alongside a return on equity of 15.8%. Investors look ahead to the next earnings report scheduled for January 12, 2027.

Dividend

The company pays an annual dividend rate of $9.28 per share, representing a dividend yield of 2.23%. Its dividend payout ratio stands at 57.6%.

Insider Buying and Selling at UnitedHealth Group Incorporated

Company insiders have also transacted in the stock recently. Officer Patrick Hugh Conway sold 500.0 shares on August 5, 2026, at a price of $410.0 for a total value of $205,000.0. Conway later sold 1,169.0 shares on August 21, 2026, at a price of $390.0 for a total value of $455,910.0.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It delivers services through four core segments: Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare. The Optum Health division focuses on care delivery, wellness programs, and health financial services for patients and providers alike.

Bottom Line

Mizuho's updated target highlights steady institutional attention on the health care giant as it trades below Wall Street's consensus expectations. Observers will track upcoming earnings on January 12, 2027, for further indicators of financial performance.